We have developed a sensitive, novel and efficient radioimmunopercipitation assay procedure, which provides conformation to ELISA and alternative to Western Blot assays for characterizing antibodies against human immunodeficiency virus-2 (HIV-2). We have used solubilized preparations of 1000X purified HIH-Z strain of HIV-2 virus spiked with purified recombinant HIV-2 gp-105 envelope protein, produced in the baculovirus expression system. Reaction of this spiked lysate with 1-125 including gp140, gp110, gp82 (dimer of gp41), p66, p34, p28 and p24. Sera from the CDC sensitivity panel and samples obtained from other sources were analyzed using this assay. This system provides a simple assay for characterizing and tittering antibodies against HIV-2, which is more specific than current ELISA methods. In addition, Bolton Hunter reagent treated proteins are well suited for biochemical studies. Future studies will use this assay to characterize the oligosaccharide side chains for gp110 and gp41 proteins to determine their role in the immune reaction.

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Intramural Research (Z01)
Project #
1Z01BG006050-01
Application #
3804862
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Center Biologics Evaluation Research Transfusion
Department
Type
DUNS #
City
State
Country
United States
Zip Code